Lamisil

Terbinafine, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical cream for skin application. It is used to treat dermatophyte infections such as tinea pedis, tinea corporis and tinea cruris in both adult and pediatric patients. The formulation is approved in the European Union and is available without a prescription in many regions.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across all markets.

Lamisil (terbinafine) is an allylamine antifungal that targets dermatophyte infections of the skin.

Tinea pedis: reduces fungal growth and alleviates itching and scaling on the feet. Tinea corporis: clears ring‑shaped lesions and relieves associated redness. Tinea cruris: eliminates fungal infection in the groin area and diminishes discomfort. Dermatophytosis (general): provides broad‑spectrum activity against common skin‑infecting fungi, promoting clearance of lesions.

Terbinafine topical therapy is generally well tolerated, but local reactions may occur.

Common Side Effects: - Burning sensation at the application site - Itching or pruritus - Redness or erythema - Dryness or peeling of the skin - Mild rash or irritation - Stinging feeling after application

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Contact dermatitis with extensive swelling - Systemic hypersensitivity reactions - Hepatotoxicity (rare with extensive use) - Significant swelling or blistering of the treated area

Before using Lamisil topical, consider the following safety measures.

Apply to intact skin: avoid broken skin, mucous membranes, or open wounds. Avoid extensive use: do not treat more than 20% of body surface without medical advice. Known hypersensitivity: discontinue if allergic reaction occurs. Pregnancy and lactation: consult a healthcare professional before use. Concurrent topical agents: assess for additive irritation when combined with other creams. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Terbinafine topical may interact with other skin products; monitor for combined effects.

Major Interactions (Avoid): - Concurrent use of systemic terbinafine oral formulations (risk of increased systemic exposure). - Application with products containing high concentrations of alcohol (may increase irritation).

Moderate Interactions (Monitor Closely): - Use with corticosteroid creams (may mask infection signs). - Use with occlusive dressings (may enhance absorption). - Combination with other antifungal agents (monitor for additive skin irritation).